Report: Lance Armstrong met with USADA to discuss admission of guilt
Banned cyclist Lance Armstrong and the U.S. Anti-Doping Agency met last month to discuss the possibility of Armstrong giving a public admission that he used performance-enhancing drugs throughout his career, reports USA Today Sports.
The report says that Armstrong met with U.S. Anti-Doping CEO Travis Tygart in early to mid-December for about an hour to discuss PED use and blood-transfusions that the agency has said that Armstrong used on his way to seven Tour de France titles.
"They (Armstrong and his advisers) were kind of beating around the bush trying to get the temperature of the situation. They were very general discussions," said the person, who spoke to USA TODAY Sports on condition of anonymity because the talks were supposed to remain confidential.
Last October, USADA released a report accusing Armstrong and other team members of rampant PED use.